Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 27,362 | 78,843 | 82,942 | 87,721 | 76,271 |
| Cost of Goods | 28,695 | 32,730 | 32,703 | 32,123 | 31,979 |
| Gross Profit | -1,333 | 46,113 | 50,239 | 55,598 | 44,292 |
| Operating Expenses | 33,484 | 32,694 | 34,533 | 34,529 | 30,275 |
| Operating Income | -34,122 | 14,149 | 16,409 | 21,192 | 14,996 |
| Interest Expense | 4,757 | 5,115 | 5,421 | 5,721 | 7,737 |
| Other Income | 3 | 3 | 3 | 3 | 3 |
| Pre-tax Income | -38,876 | 9,037 | 10,991 | 15,474 | 7,262 |
| Income Tax | -13,842 | 991 | -61,852 | -188 | 304 |
| Net Income Continuous | -25,034 | 8,046 | 72,843 | 15,662 | 6,958 |
| Net Income | $-25,034 | $8,046 | $72,843 | $15,662 | $6,958 |
| EPS Basic Total Ops | -0.69 | 0.23 | 2.06 | 0.45 | 0.21 |
| EPS Basic Continuous Ops | -0.69 | 0.23 | 2.06 | 0.45 | 0.20 |
| EPS Diluted Total Ops | -0.56 | 0.22 | 1.79 | 0.41 | 0.20 |
| EPS Diluted Continuous Ops | -0.62 | 0.22 | 1.76 | 0.38 | 0.20 |
| EBITDA(a) | $-16,903 | $31,393 | $33,629 | $38,426 | $32,072 |